Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles
Authors
Keywords
BSA, KRAS, lung cancer, siRNA delivery
Journal
PHARMACEUTICAL RESEARCH
Volume 36, Issue 9, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-10
DOI
10.1007/s11095-019-2665-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience
- (2019) Badi El Osta et al. Journal of Thoracic Oncology
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- In vitro and in vivo delivery of siRNA via VIPER polymer system to lung cells
- (2018) Daniel P. Feldmann et al. JOURNAL OF CONTROLLED RELEASE
- Protein-Based Nanoparticle Preparation via Nanoprecipitation Method
- (2018) Mohamad Tarhini et al. Materials
- Evaluation of β-Sitosterol Loaded PLGA and PEG-PLA Nanoparticles for Effective Treatment of Breast Cancer: Preparation, Physicochemical Characterization, and Antitumor Activity
- (2018) Moses Andima et al. Pharmaceutics
- siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K- ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer
- (2017) Maryna Perepelyuk et al. Molecular Therapy-Nucleic Acids
- Non‐invasive lung cancer diagnosis by detection of GATA6 and NKX2‐1 isoforms in exhaled breath condensate
- (2016) Aditi Mehta et al. EMBO Molecular Medicine
- To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
- (2016) F. Danhier JOURNAL OF CONTROLLED RELEASE
- EPR: Evidence and fallacy
- (2014) Joseph W. Nichols et al. JOURNAL OF CONTROLLED RELEASE
- Human Serum Albumin-Based Nanoparticle-Mediated In Vitro Gene Delivery
- (2014) Monica Langiu et al. PLoS One
- Multifunctional polymeric micelles for delivery of drugs and siRNA
- (2014) Aditi M. Jhaveri et al. Frontiers in Pharmacology
- Nanocarriers for intravenous injection—The long hard road to the market
- (2013) Matthias Wacker INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pooled Analysis of the Prognostic and Predictive Effects ofKRASMutation Status andKRASMutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy
- (2013) Frances A. Shepherd et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutant KRAS is a druggable target for pancreatic cancer
- (2013) E. Zorde Khvalevsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers
- (2012) S. Dogan et al. CLINICAL CANCER RESEARCH
- Protein-based nanocarriers as promising drug and gene delivery systems
- (2012) Ahmed O. Elzoghby et al. JOURNAL OF CONTROLLED RELEASE
- Polymeric micelles drug delivery system in oncology
- (2012) Jian Gong et al. JOURNAL OF CONTROLLED RELEASE
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
- (2012) Julian R. Molina et al. MAYO CLINIC PROCEEDINGS
- Nonviral Pulmonary Delivery of siRNA
- (2011) Olivia M. Merkel et al. ACCOUNTS OF CHEMICAL RESEARCH
- Pulmonary Gene Delivery Using Polymeric Nonviral Vectors
- (2011) Olivia M. Merkel et al. BIOCONJUGATE CHEMISTRY
- Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
- (2011) Davide Torti et al. EMBO Molecular Medicine
- Albumin-based nanoparticles as potential controlled release drug delivery systems
- (2011) Ahmed O. Elzoghby et al. JOURNAL OF CONTROLLED RELEASE
- Albumin: A versatile carrier for drug delivery
- (2011) Kinam Park JOURNAL OF CONTROLLED RELEASE
- The formulation of aptamer-coated paclitaxel–polylactide nanoconjugates and their targeting to cancer cells
- (2010) Rong Tong et al. BIOMATERIALS
- Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal
- (2010) Rocio Sotillo et al. NATURE
- Nanoparticle Albumin - Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery
- (2009) Qiang Fu et al. Recent Patents on Anti-Cancer Drug Discovery
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
- (2008) Felix Kratz JOURNAL OF CONTROLLED RELEASE
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started